Stay updated with breaking news from Downstream Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oil and gas separation equipment market will exhibit a CAGR of 4.70% for the forecast period of 2022-2029 and is expected to reach USD 11.37 billion by 2029
/PRNewswire/ -- Verified Market Research recently published a report, "Machine Vision Market" By Offering (Hardware, Software), By Application (Measurement,...
/PRNewswire/ -- The "Global Bioprocess Containers Market by Type(2D and 3D Bags, Accessories), Application(Process development, Upstream and Downstream...
Share: WALTHAM, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and non-rare diseases, today announced results from preclinical studies presented in poster and oral sessions at the American Society of Gene and Cell Therapy (ASGCT) 24 Challenges in achieving adequate expression in the central nervous system (CNS) with conventional AAV vectors have limited the use of gene therapy to address many devastating rare and non-rare CNS ...